| |
| |
|
| Insider
Information: |
Morningside Venture Investments Ltd |
| Relationship: |
|
| City: |
Mc98000 |
| State: |
O9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
20,304,365 |
|
|
Indirect Shares
|
1,000,000 |
|
|
| Direct
Value |
$528,303,765 |
|
|
|
Indirect Value
|
$299,500 |
|
|
| Total
Shares |
21,304,365 |
|
|
| Total
Value |
$528,603,265 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
19
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
3
|
19
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-19.0
|
| Percentage
Gain/Loss : |
 -11.7%
|
-1,590.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
10% Owner |
2021-11-18 |
12,806,342 |
2017-11-13 |
0 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
|
2023-08-15 |
1,947,993 |
2018-06-25 |
0 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
552,728 |
2018-07-30 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
10% Owner |
2023-08-15 |
4,997,302 |
2022-01-11 |
0 |
Premium* |
|
|
GreenLight Biosciences Holdings,... |
GRNA |
|
2023-07-24 |
0 |
2022-08-11 |
1,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
51 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
